Sri Lanka puts Chinese COVID-19 vaccine on hold, will use India-made shot to inoculate 14 million people - (Times Now via NewsPoints Desk)

  • Sri Lanka has put Sinopharm's COVID-19 vaccine on hold and will now use AstraZeneca's candidate made by the Serum Institute of India to inoculate 14 million people, reported Times Now.

  • Cabinet co-spokesman Ramesh Pathirana stated that the Sinopharm vaccine has not yet completed Phase III trials.

  • Moreover, he said a complete dossier related to the registration of the Chinese vaccine has also not yet been received.

  • With no takers for Sinovac, China is putting pressure on nations to buy its vaccine, according to the news source.

  • Leaked documents of correspondence between Nepal's foreign affairs ministry and the Chinese Embassy in Kathmandu show that Beijing had put pressure on Nepal to accept its vaccine without its efficiency and efficacy being established.

To read more NewsPoints articles, click here.